Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Completed

Plain-English translation of NCT02383927 on ClinicalTrials.gov ↗ · Source last updated July 2024 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(35 sites)

United States

University of California, Los Angeles, Los Angeles, California

Wihship Cancer Institute of Emory University, Atlanta, Georgia

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota